ASND
Price
$172.22
Change
-$0.73 (-0.42%)
Updated
Jun 27 closing price
Capitalization
10.42B
71 days until earnings call
BMRN
Price
$55.17
Change
+$1.07 (+1.98%)
Updated
Jun 27 closing price
Capitalization
10.58B
36 days until earnings call
Interact to see
Advertisement

ASND vs BMRN

Header iconASND vs BMRN Comparison
Open Charts ASND vs BMRNBanner chart's image
Ascendis Pharma A/S
Price$172.22
Change-$0.73 (-0.42%)
Volume$255.34K
Capitalization10.42B
BioMarin Pharmaceutical
Price$55.17
Change+$1.07 (+1.98%)
Volume$3.33M
Capitalization10.58B
ASND vs BMRN Comparison Chart in %
Loading...
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ASND vs. BMRN commentary
Jun 30, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ASND is a Buy and BMRN is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Jun 30, 2025
Stock price -- (ASND: $172.22 vs. BMRN: $55.17)
Brand notoriety: ASND and BMRN are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: ASND: 57% vs. BMRN: 165%
Market capitalization -- ASND: $10.42B vs. BMRN: $10.58B
ASND [@Biotechnology] is valued at $10.42B. BMRN’s [@Biotechnology] market capitalization is $10.58B. The market cap for tickers in the [@Biotechnology] industry ranges from $304.6B to $0. The average market capitalization across the [@Biotechnology] industry is $2.32B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ASND’s FA Score shows that 0 FA rating(s) are green whileBMRN’s FA Score has 0 green FA rating(s).

  • ASND’s FA Score: 0 green, 5 red.
  • BMRN’s FA Score: 0 green, 5 red.
According to our system of comparison, ASND is a better buy in the long-term than BMRN.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ASND’s TA Score shows that 4 TA indicator(s) are bullish while BMRN’s TA Score has 5 bullish TA indicator(s).

  • ASND’s TA Score: 4 bullish, 5 bearish.
  • BMRN’s TA Score: 5 bullish, 2 bearish.
According to our system of comparison, BMRN is a better buy in the short-term than ASND.

Price Growth

ASND (@Biotechnology) experienced а -2.65% price change this week, while BMRN (@Biotechnology) price change was +0.31% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.13%. For the same industry, the average monthly price growth was +31.22%, and the average quarterly price growth was +12.91%.

Reported Earning Dates

ASND is expected to report earnings on Sep 09, 2025.

BMRN is expected to report earnings on Aug 05, 2025.

Industries' Descriptions

@Biotechnology (+4.13% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BMRN($10.6B) and ASND($10.4B) have the same market capitalization . ASND YTD gains are higher at: 25.096 vs. BMRN (-16.066). BMRN has higher annual earnings (EBITDA): 777M vs. ASND (-287.37M). BMRN has more cash in the bank: 1.27B vs. ASND (518M). BMRN has less debt than ASND: BMRN (602M) vs ASND (847M). BMRN has higher revenues than ASND: BMRN (2.95B) vs ASND (369M).
ASNDBMRNASND / BMRN
Capitalization10.4B10.6B98%
EBITDA-287.37M777M-37%
Gain YTD25.096-16.066-156%
P/E RatioN/A20.43-
Revenue369M2.95B13%
Total Cash518M1.27B41%
Total Debt847M602M141%
FUNDAMENTALS RATINGS
ASND vs BMRN: Fundamental Ratings
ASND
BMRN
OUTLOOK RATING
1..100
5050
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
62
Fair valued
PROFIT vs RISK RATING
1..100
78100
SMR RATING
1..100
10070
PRICE GROWTH RATING
1..100
4484
P/E GROWTH RATING
1..100
10099
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

BMRN's Valuation (62) in the Biotechnology industry is in the same range as ASND (90). This means that BMRN’s stock grew similarly to ASND’s over the last 12 months.

ASND's Profit vs Risk Rating (78) in the Biotechnology industry is in the same range as BMRN (100). This means that ASND’s stock grew similarly to BMRN’s over the last 12 months.

BMRN's SMR Rating (70) in the Biotechnology industry is in the same range as ASND (100). This means that BMRN’s stock grew similarly to ASND’s over the last 12 months.

ASND's Price Growth Rating (44) in the Biotechnology industry is somewhat better than the same rating for BMRN (84). This means that ASND’s stock grew somewhat faster than BMRN’s over the last 12 months.

BMRN's P/E Growth Rating (99) in the Biotechnology industry is in the same range as ASND (100). This means that BMRN’s stock grew similarly to ASND’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ASNDBMRN
RSI
ODDS (%)
Bearish Trend 4 days ago
76%
Bullish Trend 4 days ago
72%
Stochastic
ODDS (%)
Bearish Trend 4 days ago
81%
Bullish Trend 4 days ago
63%
Momentum
ODDS (%)
Bullish Trend 4 days ago
76%
N/A
MACD
ODDS (%)
Bearish Trend 4 days ago
65%
Bullish Trend 4 days ago
68%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
74%
Bullish Trend 4 days ago
55%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
73%
Bearish Trend 4 days ago
63%
Advances
ODDS (%)
N/A
Bullish Trend 21 days ago
59%
Declines
ODDS (%)
Bearish Trend 4 days ago
77%
Bearish Trend 5 days ago
64%
BollingerBands
ODDS (%)
Bearish Trend 4 days ago
64%
Bullish Trend 4 days ago
73%
Aroon
ODDS (%)
Bullish Trend 4 days ago
79%
Bearish Trend 4 days ago
63%
View a ticker or compare two or three
Interact to see
Advertisement
ASND
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BMRN
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
ETFs / NAMEPrice $Chg $Chg %
DFSU39.140.26
+0.67%
Dimensional US Sustainability Core 1 ETF
GJUL38.550.12
+0.31%
FT Vest U.S. Eq Mod Buffr ETF - Jul
DTF11.190.03
+0.23%
DTF Tax-Free Income 2028 Term Fund
PSIL14.09-0.01
-0.04%
AdvisorShares Psychedelics ETF
QQQG22.80-0.08
-0.35%
Pacer Nasdaq 100 Top 50 Csh CwsGrLdrsETF

ASND and

Correlation & Price change

A.I.dvisor indicates that over the last year, ASND has been loosely correlated with NUVL. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if ASND jumps, then NUVL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ASND
1D Price
Change %
ASND100%
-0.42%
NUVL - ASND
39%
Loosely correlated
+0.68%
ZNTL - ASND
35%
Loosely correlated
-6.35%
KYMR - ASND
32%
Poorly correlated
-3.48%
ZYME - ASND
32%
Poorly correlated
+0.81%
BMRN - ASND
31%
Poorly correlated
+1.98%
More

BMRN and

Correlation & Price change

A.I.dvisor indicates that over the last year, BMRN has been loosely correlated with ITOS. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if BMRN jumps, then ITOS could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BMRN
1D Price
Change %
BMRN100%
+1.98%
ITOS - BMRN
49%
Loosely correlated
-0.60%
IBO - BMRN
46%
Loosely correlated
-18.26%
IONS - BMRN
42%
Loosely correlated
+0.05%
TECH - BMRN
40%
Loosely correlated
-1.82%
KRYS - BMRN
40%
Loosely correlated
-2.60%
More